semaglutide alzheimer phase 3 ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway semaglutide alzheimer's clinical trial Oral

JAMA Pediatr 2016;170:964-70

Here are the biggest risks you face when integrating GLP-1 medications with intermittent fasting and smart, evidence-based strategies to mitigate them: Increased Risk of Muscle Loss Both GLP-1s and intermittent fasting can reduce your overall calorie intake, sometimes drastically

Montani, J

Clin Obes 2021;11:e12481

Injecting too shallow (intradermal) or too deep (intramuscular) can affect absorption rates and pharmacokinetics

At Illume Med Spa, we're at the forefront of integrating these innovations into personalized wellness plans, offering our clients effective and sustainable weight loss solutions